Annual Total Liabilities
N/A
December 1, 2024
Summary
- ABBV annual total liabilities is not available.
Performance
ABBV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
N/A
December 1, 2024
Summary
- ABBV quarterly total liabilities is not available.
Performance
ABBV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ABBV Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ABBV Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
AbbVie Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $137.35 B(+1.7%) |
| Jun 2024 | - | $135.12 B(-4.1%) |
| Mar 2024 | - | $140.83 B(+13.3%) |
| Dec 2023 | $124.31 B(+2.3%) | $124.31 B(+0.2%) |
| Sep 2023 | - | $124.09 B(+1.3%) |
| Jun 2023 | - | $122.47 B(+1.0%) |
| Mar 2023 | - | $121.24 B(-0.2%) |
| Dec 2022 | $121.52 B(-7.3%) | $121.52 B(-3.0%) |
| Sep 2022 | - | $125.30 B(-2.5%) |
| Jun 2022 | - | $128.50 B(+1.3%) |
| Mar 2022 | - | $126.90 B(-3.2%) |
| Dec 2021 | $131.09 B(-4.6%) | $131.09 B(-3.1%) |
| Sep 2021 | - | $135.28 B(-0.1%) |
| Jun 2021 | - | $135.38 B(-1.0%) |
| Mar 2021 | - | $136.77 B(-0.5%) |
| Dec 2020 | $137.47 B(+41.3%) | $137.47 B(+2.3%) |
| Sep 2020 | - | $134.33 B(-0.3%) |
| Jun 2020 | - | $134.80 B(+36.7%) |
| Mar 2020 | - | $98.61 B(+1.4%) |
| Dec 2019 | $97.29 B(+43.5%) | $97.29 B(+43.8%) |
| Sep 2019 | - | $67.67 B(+3.0%) |
| Jun 2019 | - | $65.71 B(+1.7%) |
| Mar 2019 | - | $64.59 B(-4.7%) |
| Dec 2018 | $67.80 B | $67.80 B(-1.9%) |
| Sep 2018 | - | $69.08 B(+6.3%) |
| Jun 2018 | - | $65.02 B(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $65.79 B(+0.2%) |
| Dec 2017 | $65.69 B(+6.9%) | $65.69 B(+5.7%) |
| Sep 2017 | - | $62.15 B(+1.9%) |
| Jun 2017 | - | $60.98 B(+0.5%) |
| Mar 2017 | - | $60.67 B(-1.3%) |
| Dec 2016 | $61.46 B(+25.2%) | $61.46 B(+2.2%) |
| Sep 2016 | - | $60.16 B(-2.3%) |
| Jun 2016 | - | $61.57 B(+25.5%) |
| Mar 2016 | - | $49.08 B(-0.1%) |
| Dec 2015 | $49.10 B(+90.5%) | $49.10 B(-1.7%) |
| Sep 2015 | - | $49.97 B(+3.3%) |
| Jun 2015 | - | $48.35 B(+90.9%) |
| Mar 2015 | - | $25.32 B(-1.7%) |
| Dec 2014 | $25.77 B(+4.3%) | $25.77 B(+8.2%) |
| Sep 2014 | - | $23.81 B(-0.1%) |
| Jun 2014 | - | $23.83 B(-0.6%) |
| Mar 2014 | - | $23.96 B(-3.0%) |
| Dec 2013 | $24.71 B(+4.5%) | $24.71 B(+0.1%) |
| Sep 2013 | - | $24.68 B(+1.3%) |
| Jun 2013 | - | $24.35 B(+0.6%) |
| Mar 2013 | - | $24.21 B(+2.4%) |
| Dec 2012 | $23.64 B(+211.6%) | $23.64 B(+234.9%) |
| Sep 2012 | - | $7.06 B(+13.8%) |
| Jun 2012 | - | $6.20 B(-10.2%) |
| Mar 2012 | - | $6.91 B(-8.9%) |
| Dec 2011 | $7.59 B(+39.7%) | $7.59 B |
| Dec 2010 | $5.43 B | - |
FAQ
- What is the all time high annual total liabilities for AbbVie?
- What is the all time high quarterly total liabilities for AbbVie?
What is the all time high annual total liabilities for AbbVie?
AbbVie all-time high annual total liabilities is $137.47 B
What is the all time high quarterly total liabilities for AbbVie?
AbbVie all-time high quarterly total liabilities is $140.83 B